IMAX Corporation Reports First Quarter 2020 Results
HIGHLIGHTS
- A solid balance sheet and ample cash puts the Company in a strong position to operate through this historic period of COVID-19-driven theater closures
- In response to COVID-19, the Company has implemented cost reductions and drew on its revolver, ending the quarter with
$352.3 million in consolidated cash and its$300 million revolver fully drawn - The Company estimates a monthly cash burn rate of approximately
$10 million and remains confident in its ability to operate through an extended business shut down and a zero revenue environment - First quarter 2020 revenue decreased 56.5% versus 2019 to
$34.9 million - First quarter 2020 net (loss) attributable to common shareholders was
($49.4) million . Non-GAAP adjusted EBITDA (loss) was($4.4) million versus$28.5 million in the prior-year period - The Company is actively preparing to reopen to what is projected to be an IMAX-friendly second-half release slate
Three Months Ended | ||||||
(In millions of | 2020 | 2019 | YoY % | |||
Change | ||||||
Total Revenue | $ | 34.9 | $ | 80.2 | (56.5%) | |
Gross Margin | $ | 5.1 | $ | 45.1 | (88.7%) | |
Gross Margin (%) | 14.6% | 56.3% | ||||
Net (Loss) Income(1) | $ | (49.4) | $ | 8.3 | N/A | |
Diluted Net (Loss) Income Per Share(1) | $ | (0.82) | $ | 0.13 | N/A | |
Adj. Net (Loss) Income Per Share(1)(2) | $ | (0.48) | $ | 0.18 | N/A | |
Adjusted EBITDA(2) | $ | (4.4) | $ | 28.5 | N/A | |
Adj. EBITDA Margin (%)(2) | (13.1%) | 39.8% | N/A | |||
(1)Attributable to common shareholders | ||||||
(2)Non-GAAP Financial Measure | ||||||
Note: For the definition and reconciliations of reported results to non-GAAP financial results, please refer to the | ||||||
The closure of substantially all of the Company's theater network due to the global outbreak of the COVID-19 pandemic drove results down in the first quarter. Also contributing to the Company's first quarter loss was a
"IMAX is uniquely positioned to manage through a temporary shutdown of theaters as a result of strategic planning which led to our strong financial position, valuable brand, and vast global footprint. With our strong cash balance and continued cost discipline, we believe that we will be ready to program our network, accelerate our theater business, and once again bring audiences the world's most immersive entertainment experience when ready," said IMAX CEO
"When global economies restart, and theaters reopen, we believe audiences will turn to strong, trusted brands like IMAX. In 2019, IMAX delivered a record year across global, international, and local language box office — underscoring the strength of our brand and product offering throughout an increasingly diverse geographic footprint."
"We are working closely with our studio partners to reshape our slate in the second half of 2020 and into 2021 — a period that is now scheduled to see an impressive offering of marquee blockbuster films. Operationally, we are focused on ensuring that we can support this rich content pipeline with our proprietary post-production process and our enhanced marketing capabilities."
"We continue to monitor the situation and carefully plan for the reopening of theaters in
"Above all, we are focused on the safety and well-being of our employees and our audiences. Our thoughts remain with those impacted by this pandemic around the world, as we continue to support the efforts of local governments and our industry to prioritize public health."
First Quarter Segment Results(1)
IMAX Technology Network | IMAX Technology Sales and | |||||||||
Revenue | Gross | Gross | Revenue | Gross | Gross | |||||
1Q20 | $ | 16.6 | $ | 2.8 | 17.0% | $ | 15.1 | $ | 4.7 | 31.3% |
1Q19 | 46.0 | 31.7 | 68.9% | 30.1 | 13.1 | 43.5% | ||||
% change | (63.9%) | (91.1%) | (49.9%) | (63.9%) | ||||||
(1)Please refer to the Company's Form 10-Q for the period ended | ||||||||||
IMAX Technology Network
- IMAX Technology Network revenues decreased 63.9% to
$16.6 million in the first quarter of 2020, compared to$46.0 million in the prior-year period. The decline in revenue was driven by a 62.9% decrease in IMAX global box office connected to COVID-19-related theater closures. - Total gross margin for the IMAX Technology Network business was 17.0% in the most recent quarter, compared to 68.9% in the prior-year period. The year-over-year decrease in total gross margin was primarily driven by lower revenue.
IMAX Technology Sales and Maintenance
- IMAX Technology Sales and Maintenance revenues decreased 49.9% to
$15.1 million in the first quarter of 2020, compared with$30.1 million in the prior year period. - Total gross margin for IMAX Technology Sales and Maintenance was 31.3% compared to 43.5% in the prior year period. The year-over-year decline in total gross margin was primarily driven by fewer sales and sales-type leases due to COVID-19 related delays in theater installations and lower maintenance revenue as such services were not able to be provided while theaters are closed.
Cash Balances and Outstanding Debt
Total cash and cash equivalents as of
Share Count and Capital Return
- The weighted average diluted shares outstanding at the end of the first quarter of 2020 declined 1.9% to 60.4 million, compared to 61.6 million in first quarter 2019, due primarily to share repurchase activity. During the quarter, a total of 2.5 million shares were repurchased at an average price of
$14.72 for a total value of approximately$36.6 million . A total of$89.4 million remains available under the Company's outstanding share repurchase authorization, which expires inJune 2020 . - During the first quarter of 2020, IMAX China repurchased a total of 480.6 thousand shares at an average price of
$1.85 for a total value of approximately$890.8 thousand .
Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.
Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.
The information posted on the Company's corporate and Investor Relations website may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases,
Conference Call
The Company will host a conference call today at
About
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.
IMAX is headquartered in
IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, and IMAX nXos® are trademarks of
For additional information please contact:
Investors: 212-821-0187 | Media: 212-821-0102 |
Forward-Looking Statements
This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of
PrimaryReporting Groups
The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements; (iii) IMAX Systems, (iv) IMAX Maintenance; (v) Other Theater Business; (vi) New Business Initiatives; (vii) Film Distribution; and (viii)
(i) IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from the Joint Revenue Sharing Arrangement ("JRSA") segment;
(ii) IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment;
(iii) New Business Initiatives, which is a segment that includes activities related to the exploration of new lines of business and new initiatives outside of the Company's core business; and
(iv) Film Distribution and Post-production, which includes activities related to the distribution of films primarily for the Company's institutional theater partners (through the Film Distribution segment) and the provision of film post-production and quality control services (through the
Non-GAAP Financial Measures
In this release, the Company presents adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, free cash flow and return on invested capital as supplemental measures of the Company's performance, which are not recognized under
The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual charges to net (loss) income attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.
In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Company's credit agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Company's credit agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its credit agreement requirements in the current period. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.
EBITDA is defined as net (loss) income excluding (i) interest income (expense), net; (ii) income tax provision (benefit); and (iii) depreciation and amortization. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) gain (loss) from equity accounted investments; (ii) stock and other non-cash compensation; (iii) exit costs, restructuring charges and associated impairments; (iv) change in fair value of equity investment; (v) write-downs, net of recoveries, including asset impairments and receivable provisions; and (vi) adjusted EBITDA attributable to non-controlling interests.
Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the condensed consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.
These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.
Signings and Installations | |||||||||
Three Months | |||||||||
Theater System Signings: | 2020 | 2019 | |||||||
Full new sales and sales-type lease arrangements | 2 | 9 | |||||||
New hybrid joint revenue sharing lease arrangements | - | 3 | |||||||
New traditional joint revenue sharing arrangements | 2 | 2 | |||||||
Total new IMAX Theater Systems | 4 | 14 | |||||||
Upgrades of IMAX Theater Systems | 11 | 9 | |||||||
Total IMAX Theater System signings | 15 | 23 | |||||||
Three Months | |||||||||
Theater System Installations: | 2020 | 2019 | |||||||
Full new sales and sales-type lease arrangements | 2 | 6 | |||||||
New hybrid joint revenue sharing lease arrangements | 1 | 4 | |||||||
New traditional joint revenue sharing arrangements | 2 | 4 | |||||||
Total new IMAX Theater Systems | 5 | 14 | |||||||
Upgrades of IMAX theater systems | 7 | 3 | |||||||
Total IMAX Theater System installations | 12 | 17 | |||||||
Three Months | |||||||||
Theater Sales Backlog: | 2020 | 2019 | |||||||
Sales and sales-type lease arrangements | 180 | 182 | |||||||
Joint revenue sharing arrangements | |||||||||
Hybrid lease arrangements | 138 | 117 | |||||||
Traditional arrangements | 215 | (1) | 272 | (1) | |||||
Total IMAX Theater System backlog | 533 | 571 | |||||||
Three Months | |||||||||
IMAX Theater System Network: | 2020 | 2019 | |||||||
Sales and sales-type lease arrangements | 659 | 611 | |||||||
Hybrid joint revenue sharing lease arrangements | 136 | 128 | |||||||
Traditional joint revenue sharing lease arrangements | 731 | 681 | |||||||
1,526 | 1,420 | ||||||||
14 | 14 | ||||||||
76 | 80 | ||||||||
Total IMAX Theater System network | 1,616 | 1,514 | |||||||
(1) Includes 34 IMAX Theater Systems where the customer has the option to convert from joint revenue sharing arrangements | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||
(In thousands of | |||||||
(Unaudited) | |||||||
Three Months Ended | |||||||
2020 | 2019 | ||||||
Revenues(1) | |||||||
Technology sales | $ | 5,662 | $ | 15,200 | |||
Image enhancement and maintenance services | 20,721 | 44,147 | |||||
Technology rentals | 5,971 | 18,170 | |||||
Finance income | 2,548 | 2,681 | |||||
34,902 | 80,198 | ||||||
Costs and expenses applicable to revenues(1) | |||||||
Technology sales | 3,869 | 9,435 | |||||
Image enhancement and maintenance services | 17,816 | 19,243 | |||||
Technology rentals | 8,131 | 6,380 | |||||
29,816 | 35,058 | ||||||
Gross margin | 5,086 | 45,140 | |||||
Selling, general and administrative expenses | 28,636 | 27,649 | |||||
Research and development | 2,200 | 1,136 | |||||
Amortization of intangibles | 1,321 | 1,075 | |||||
Credit loss expense | 10,217 | 431 | |||||
Asset impairments | 1,151 | - | |||||
Exit costs, restructuring charges and associated impairments | - | 850 | |||||
(Loss) Income from operations | (38,439) | 13,999 | |||||
Change in fair value of equity securities | (4,539) | 2,491 | |||||
Retirement benefits non-service expense | (116) | (160) | |||||
Interest income | 365 | 570 | |||||
Interest expense | (648) | (681) | |||||
(Loss) income before taxes | (43,377) | 16,219 | |||||
Income tax expense | (15,505) | (3,648) | |||||
Equity in losses of investees, net of tax | (529) | (84) | |||||
Net (loss) income | (59,411) | 12,487 | |||||
Less: Net loss (income) attributable to non-controlling interests | 10,057 | (4,222) | |||||
Net (loss) income attributable to common shareholders | $ | (49,354) | $ | 8,265 | |||
Net (loss) income per share attributable to common shareholders - | |||||||
Net (loss) income per share — basic and diluted | $ | (0.82) | $ | 0.13 | |||
Weighted average number of shares outstanding (000's): | |||||||
Basic | 60,418 | 61,377 | |||||
Fully Diluted | 60,418 | 61,559 | |||||
Additional Disclosure: | |||||||
Depreciation and amortization(2) | $ | 15,252 | $ | 14,211 | |||
(1) In the first quarter of 2020, the Company updated certain account names within revenues and costs and | |||||||
(2) Includes | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||
In accordance with United States Generally Accepted Accounting Principles | ||||
(In thousands of | ||||
(Unaudited) | ||||
2020 | 2019 | |||
Assets | ||||
Cash and cash equivalents | $ 352,277 | $ 109,484 | ||
Accounts receivable, net of allowance for credit losses | 64,818 | 99,513 | ||
Financing receivables, net of allowance for credit losses | 121,112 | 128,038 | ||
Variable consideration receivable from contracts, net of allowance for credit losses | 38,694 | 40,040 | ||
Inventories | 61,635 | 42,989 | ||
Prepaid expenses | 11,558 | 10,237 | ||
Film assets | 15,645 | 17,921 | ||
Property, plant and equipment | 294,361 | 306,849 | ||
Investment in equity securities | 11,131 | 15,685 | ||
Other assets | 24,559 | 25,034 | ||
Deferred income tax assets | 37,967 | 23,905 | ||
Other intangible assets | 29,542 | 30,347 | ||
Goodwill | 39,027 | 39,027 | ||
Total assets | $ 1,102,326 | $ 889,069 | ||
Liabilities | ||||
Bank indebtedness | $ 298,355 | $ 18,229 | ||
Accounts payable | 25,296 | 20,414 | ||
Accrued and other liabilities | 111,850 | 112,779 | ||
Deferred revenue | 103,267 | 94,552 | ||
Deferred income tax liabilities | 19,681 | — | ||
Total liabilities | 558,449 | 245,974 | ||
Commitments and contingencies | ||||
Non-controlling interests | 5,500 | 5,908 | ||
Shareholders' equity | ||||
Capital stock common shares — no par value. Authorized — unlimited number. | ||||
58,878,749 issued and 58,786,752 outstanding ( | 405,583 | 423,386 | ||
Less: | (1,419) | (4,038) | ||
Other equity | 168,892 | 171,789 | ||
Accumulated deficit | (108,428) | (40,253) | ||
Accumulated other comprehensive loss | (5,759) | (3,190) | ||
Total shareholders' equity attributable to common shareholders | 458,869 | 547,694 | ||
Non-controlling interests | 79,508 | 89,493 | ||
Total shareholders' equity | 538,377 | 637,187 | ||
Total liabilities and shareholders' equity | $ 1,102,326 | $ 889,069 | ||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
(In thousands of | |||||||
(Unaudited) | |||||||
Three Months Ended | |||||||
2020 | 2019 | ||||||
Cash provided by (used in): | |||||||
Operating Activities | |||||||
Net (loss) income | $ | (59,411) | $ | 12,487 | |||
Adjustments to reconcile net (loss) income to cash from operating activities: | |||||||
Depreciation and amortization | 15,252 | 14,211 | |||||
Credit loss expense | 10,217 | 431 | |||||
Write-downs | 4,403 | 266 | |||||
Deferred income tax expense | 5,627 | 688 | |||||
Share and other non-cash compensation | 4,309 | 4,524 | |||||
Unrealized foreign currency exchange loss (gain) | 223 | (24) | |||||
Change in fair value of equity securities | 4,539 | (2,491) | |||||
Equity in losses of investees | 529 | 84 | |||||
Investment in film assets | (3,064) | (3,740) | |||||
Changes in other non-cash operating assets and liabilities | 23,342 | (27,105) | |||||
Net cash provided by (used in) operating activities | 5,966 | (669) | |||||
Investing Activities | |||||||
Purchase of property, plant and equipment | (271) | (2,237) | |||||
Investment in joint revenue sharing equipment | (1,580) | (9,716) | |||||
Acquisition of other intangible assets | (862) | (540) | |||||
Investment in equity securities | — | (15,153) | |||||
Net cash used in investing activities | (2,713) | (27,646) | |||||
Financing Activities | |||||||
Increase in bank indebtedness | 280,000 | 35,000 | |||||
Repayment of bank indebtedness | — | (15,000) | |||||
Settlement of restricted share units and options | (1,667) | (4,987) | |||||
(1,419) | (4,207) | ||||||
Repurchase of common shares, IMAX China | (891) | (1,767) | |||||
Taxes withheld and paid on employee stock awards vested | (236) | (219) | |||||
Common shares issued - stock options exercised | — | 803 | |||||
Repurchase of common shares | (36,624) | — | |||||
Net cash provided by financing activities | 239,163 | 9,623 | |||||
Effects of exchange rate changes on cash | 377 | 186 | |||||
Increase (decrease) in cash and cash equivalents during period | 242,793 | (18,506) | |||||
Cash and cash equivalents, beginning of period | 109,484 | 141,590 | |||||
Cash and cash equivalents, end of period | $ | 352,277 | $ | 123,084 | |||
Three Months Ended | |||||
2020 | 2019 | ||||
Revenue | |||||
IMAX Technology Network | |||||
IMAX DMR | $ 10,629 | $ 27,950 | |||
Joint revenue sharing arrangements, contingent rent | 5,971 | 18,044 | |||
16,600 | 45,994 | ||||
IMAX Technology Sales and Maintenance | |||||
IMAX Systems | 5,688 | 13,026 | |||
Joint revenue sharing arrangements, fixed fees | 770 | 2,539 | |||
IMAX Maintenance | 7,370 | 12,951 | |||
Other Theater Business | 1,263 | 1,626 | |||
15,091 | 30,142 | ||||
New Business Initiatives | 478 | 834 | |||
Film Distribution and Post-Production | 2,494 | 2,662 | |||
34,663 | 79,632 | ||||
Other | 239 | 566 | |||
Total revenues | $ 34,902 | $ 80,198 | |||
Gross Margin | |||||
IMAX Technology Network | |||||
IMAX DMR(1) | $ 4,443 | $ 19,775 | |||
Joint revenue sharing arrangements, contingent rent(1) | (1,618) | 11,935 | |||
2,825 | 31,710 | ||||
IMAX Technology Sales and Maintenance | |||||
IMAX Systems (1) | 3,176 | 7,052 | |||
Joint revenue sharing arrangements, fixed fees(1) | 179 | 295 | |||
IMAX Maintenance | 759 | 5,281 | |||
Other Theater Business | 610 | 475 | |||
4,724 | 13,103 | ||||
New Business Initiatives | 361 | 619 | |||
Film Distribution and Post-Production (1) | (1,935) | (25) | |||
5,975 | 45,407 | ||||
Other | (889) | (267) | |||
Total Segment Margin | $ 5,086 | $ 45,140 | |||
(1) | IMAX DMR gross margin includes marketing costs of | ||||
OTHER INFORMATION
(in thousands of
Non-GAAP Financial Measures:
In this release, the Company presents adjusted net (loss) income attributable to common shareholders and adjusted net (loss) income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, free cash flow and return on invested capital as supplemental measures of the Company's performance, which are not recognized under
The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company's financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual charges to net (loss) income attributable to common shareholders. Although share-based compensation is an important aspect of the Company's employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.
In addition to the non-GAAP financial measures discussed above, management also uses "EBITDA," as such term is defined in the Company's credit agreement, and which is referred to herein as "Adjusted EBITDA per Credit Facility." As allowed by the Company's credit agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company's operating performance and to provide additional information with respect to the Company's compliance against its credit agreement requirements in the current period. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry to evaluate, assess and benchmark the Company's results.
EBITDA is defined as net (loss) income excluding (i) interest income (expense), net; (ii) income tax provision (benefit); and (iii) depreciation and amortization. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) gain (loss) from equity accounted investments; (ii) stock and other non-cash compensation; (iii) exit costs, restructuring charges and associated impairments; (iv) change in fair value of equity investment; (v) write-downs, net of recoveries, including asset impairments and receivable provisions; and (vi) adjusted EBITDA attributable to non-controlling interests.
These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.
For the | For the | For the | For the | |||||||||||
Three Months | Three Months | 12 Months | 12 Months | |||||||||||
Reported net (loss) income attributable to common shareholders | $ | (49,354) | $ | 8,265 | $ | (10,753) | $ | 22,604 | ||||||
Add (subtract): | ||||||||||||||
Provision for income taxes | 10,949 | 2,721 | 21,369 | 5,193 | ||||||||||
Interest expense, net of interest income | 253 | 270 | 930 | 655 | ||||||||||
Depreciation and amortization, including film asset amortization | 14,012 | 12,964 | 59,502 | 53,148 | ||||||||||
EBITDA | $ | (24,140) | $ | 24,220 | $ | 71,048 | $ | 81,600 | ||||||
Stock and other non-cash compensation | 4,158 | 4,414 | 22,697 | 22,594 | ||||||||||
Change in fair value of equity investment | 3,165 | (1,700) | 5,218 | (1,700) | ||||||||||
Write-downs, including asset impariments and credit loss expense | 11,928 | 655 | 17,040 | 2,917 | ||||||||||
Exit costs, restructuring charges, and associated impairments | - | 850 | - | 9,690 | ||||||||||
Legal arbitration award | - | - | - | 11,737 | ||||||||||
Executive transition costs | - | - | - | 2,994 | ||||||||||
Loss from equity accounted investments | 529 | 84 | 442 | 371 | ||||||||||
Adjusted EBITDA attributable to common shareholders | $ | (4,360) | $ | 28,523 | $ | 116,445 | $ | 130,203 | ||||||
Adjusted revenues attributable to common shareholders(2) | $ | 33,306 | $ | 71,724 | $ | 319,236 | $ | 332,489 | ||||||
Adjusted EBITDA margin attributable to common shareholders | (13.1) | % | 39.8 | % | 36.5 | % | 39.2 | % | ||||||
(1) | Senior Secured Net Leverage Ratio calculated using twelve months ended Adjusted EBITDA per Credit Facility. | ||||||||||||||||||||
(2) | Three months ended | Three months ended | 12 months ended | 12 months ended | |||||||||||||||||
Total revenues | $ | 34,902 | $ | 80,198 | $ | 350,368 | $ | 369,615 | |||||||||||||
$ | 5,269 | $ | 26,681 | $ | 102,882 | $ | 116,055 | ||||||||||||||
Non-controlling interest ownership percentage(3) | 30.29% | 31.76% | 30.26% | 31.99% | |||||||||||||||||
Deduction for non-controlling interest share of revenues | (1,596) | 8,474 | (31,132) | (37,126) | |||||||||||||||||
Adjusted revenues attributable to common shareholders | $ | 33,306 | $ | 71,724 | $ | 319,236 | $ | 332,489 | |||||||||||||
(3) | Weighted average ownership percentage for change in non-controlling interest share | ||||||||||||||||||||
Adjusted Net (Loss) Income Attributable to Common Shareholders and Adjusted Diluted Per Share Calculations (In thousands of (Unaudited) | ||||||||||
Net Income | Diluted EPS | Net Income | Diluted EPS | |||||||
Reported net (loss) income attributable to common shareholders | $ (49,354) | $ (0.82) | $ 8,265 | $ 0.13 | ||||||
Adjustments: | ||||||||||
Share-based compensation | 4,075 | 0.07 | 4,277 | 0.07 | ||||||
Exit costs, restructuring charges and associated impairments | — | — | 850 | 0.01 | ||||||
Change in fair value of equity securities | 3,165 | 0.05 | (1,700) | (0.02) | ||||||
Tax impact on items listed above | (338) | (0.01) | (881) | (0.01) | ||||||
Income tax expense related to removal of indefinitely reinvested assertion on the | 13,726 | 0.23 | — | — | ||||||
Adjusted net (loss) income | $ (28,726) | $ (0.48) | $ 10,811 | $ 0.18 | ||||||
Weighted average basic shares outstanding | 60,418 | 61,377 | ||||||||
Weighted average diluted shares outstanding | 60,418 | 61,559 | ||||||||
Free Cash Flow:
Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net (loss) income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:
Three Months Ended | |||
Net cash provided by operating activities | $ | 5,966 | |
Net cash used in investing activities | (2,713) | ||
Free cash flow | $ | 3,253 | |
View original content to download multimedia:http://www.prnewswire.com/news-releases/imax-corporation-reports-first-quarter-2020-results-301050093.html
SOURCE
